Azafaros logo

Azafaros

Developer of therapeutics for rare lysosomal storage disorders.

2

Funding Rounds

$174.5m

Money raised

Overview

Developer of therapeutics for rare lysosomal storage disorders.

Funding

Funding series

Funding Series Analysis

The company Azafaros has raised a total of $174.5m in funding over 2 rounds.

Key Insights:

  • Azafaros Series B Round, May 2025: $147m
  • Azafaros , February 2020: $27.5m
Azafaros logo
Azafaros Series B Round, May 2025 $147m
Azafaros logo
Azafaros , February 2020 $27.5m

Industries

Azafaros is active in the following industries: